Our findings revealed for the first time a potential oncogenic role for CCDC34 in bladder carcinoma pathogenesis and it may serve as a biomarker or even a therapeutic target for bladder cancer. The gene discussed is CCDC34; the disease is urinary bladder carcinoma.